journal article·2021-11Open access

Death Pathways of Cancer Cells Modulated by Surface Molecule Density on Gold Nanorods

Fulei Zhang, Yi Hou, Minhui Zhu, Bo Deng, Mengxin Zhao, Xiandi Zhu, Yun Sun, Di Chen, Cheng Jiang, Liming Wang, Chunying Chen, Huaiwen Chen, Han Chen, Hongliang Zheng, Wei Li

Advanced Science· Volume 8· Issue 22

Abstract

Abstract Necrosis induces strong inflammation with undesirable implications in clinics compared with apoptosis. Fortunately, the switch between necrosis and apoptosis could be realized by tailoring the appropriate structural properties of gold nano rods (GNRs) that could precisely modulate cell death pathways. Herein, the intracellular interaction between GNRs and organelles is monitored and it is found that lysosomes dominates necrosis/apoptosis evoking. Then the surface molecule density of GNRs, which is first defined as ρ surf. molecule ( N surf. molecules /( a × π × Diameter × Length)), mediates lysosome activities as the membrane permeabilization (LMP), the Cathepsin B and D release, the cross‐talk between lysosome and different organelles, which selectively evokes apoptosis or necrosis and the production of TNF‐ α from macrophages. GNRs with small ρ surf. molecule mainly induce apoptosis, while with large ρ surf. molecule they greatly contribute to necrosis. Interestingly, necrosis can be suppressed by GNRs with higher ρ surf. molecule due to the overexpression of key protease caspase 8, which cleaves the RIP1‐RIP3 complex and activates caspase 3 followed by necrosis to apoptosis transition. This investigation indicates that the ρ surf. molecule greatly affects the utility of nanomaterials and different structural properties of nanomaterials have different implications in clinics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Phagocytosis and Immune Regulation · Cell death mechanisms and regulation · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nanomedicine & International Joint Cancer Institute Naval Medical University Shanghai 200433 China

Department of Otolaryngology Head & Neck Surgery Shanghai Changhai Hospital Naval Medical University 168 Changhai Road Shanghai 200433 China

State Key Laboratory of New Textile Materials and Advanced Processing Technologies Wuhan 430073 China

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety Institute of High Energy Physics and National Center for Nanoscience and Technology of China Chinese Academy of Sciences Beijing 100049 China

Department of General Surgery Navy No.905 Hospital of Chinese People's Liberation Army Naval Medical University Shanghai 200050 China

Funding

National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1002/smll.20070021710.1002/smll.200700217 ↗
2. Kim K. · Nano Lett. · 2010 · 10
3. 10.1021/nl062962v10.1021/nl062962v ↗
4. 10.1016/j.jconrel.2017.03.03810.1016/j.jconrel.2017.03.038 ↗
5. 10.1021/acs.nanolett.6b0173010.1021/acs.nanolett.6b01730 ↗
6. Shen C. · J. Am. Chem. Soc. · 2016
7. 10.1021/nl070345g10.1021/nl070345g ↗
8. 10.1016/j.bios.2011.06.00710.1016/j.bios.2011.06.007 ↗
9. 10.2217/nnm-2016-013910.2217/nnm-2016-0139 ↗
10. 10.1002/ange.20151173310.1002/ange.201511733 ↗
11. 10.1021/nn103476x10.1021/nn103476x ↗
12. 10.2217/nnm.12.8810.2217/nnm.12.88 ↗
13. 10.1021/am403385710.1021/am4033857 ↗
14. 10.1021/nn202155y10.1021/nn202155y ↗
15. 10.1016/j.biomaterials.2011.11.06310.1016/j.biomaterials.2011.11.063 ↗
16. Zhang F. · Nanomedicine · 2017
17. 10.1016/0092-8674(95)90072-110.1016/0092-8674(95)90072-1 ↗
18. 10.1016/j.ajur.2016.08.00810.1016/j.ajur.2016.08.008 ↗
19. 10.1016/j.cell.2010.12.01710.1016/j.cell.2010.12.017 ↗
20. 10.1021/cm303708p10.1021/cm303708p ↗
21. 10.1016/j.addr.2010.02.00210.1016/j.addr.2010.02.002 ↗
22. 10.1007/s13404-012-0067-410.1007/s13404-012-0067-4 ↗
23. 10.1016/j.copbio.2017.02.00910.1016/j.copbio.2017.02.009 ↗
24. 10.1021/nn301389c10.1021/nn301389c ↗
25. 10.1021/nl503777s10.1021/nl503777s ↗
26. 10.1021/nl103992v10.1021/nl103992v ↗
27. 10.1038/nrm221610.1038/nrm2216 ↗
28. 10.1038/2887910.1038/28879 ↗
29. 10.1038/nrc173810.1038/nrc1738 ↗
30. 10.1038/sj.onc.120751210.1038/sj.onc.1207512 ↗
31. 10.1016/j.bbcan.2005.11.00310.1016/j.bbcan.2005.11.003 ↗
32. 10.1002/anie.20140969310.1002/anie.201409693 ↗
33. 10.1084/jem.2007215210.1084/jem.20072152 ↗
34. 10.1016/S0002-9440(10)64160-010.1016/S0002-9440(10)64160-0 ↗
35. 10.1002/smll.20170181510.1002/smll.201701815 ↗
36. 10.1016/j.cell.2009.05.02110.1016/j.cell.2009.05.021 ↗
37. 10.1038/s41586-019-1752-810.1038/s41586-019-1752-8 ↗
38. 10.4161/15384101.2014.99119410.4161/15384101.2014.991194 ↗
39. 10.1002/adhm.20167000210.1002/adhm.201670002 ↗
40. 10.1038/srep1571210.1038/srep15712 ↗
41. 10.1016/j.biomaterials.2012.04.01610.1016/j.biomaterials.2012.04.016 ↗
42. 10.1016/j.biomaterials.2011.01.07510.1016/j.biomaterials.2011.01.075 ↗
43. 10.1016/j.jconrel.2020.06.00110.1016/j.jconrel.2020.06.001 ↗
44. 10.1101/gad.13.19.251410.1101/gad.13.19.2514 ↗
45. 10.1084/jem.2002195210.1084/jem.20021952 ↗
46. 10.1016/j.polymer.2011.06.02610.1016/j.polymer.2011.06.026 ↗
47. 10.2217/nnm.14.12710.2217/nnm.14.127 ↗
48. 10.1038/s41565-018-0272-210.1038/s41565-018-0272-2 ↗
49. 10.1016/j.biomaterials.2010.06.05110.1016/j.biomaterials.2010.06.051 ↗
50. Pei W. · Adv. Funct. Mater. · 2020